|3 Months Ended|
Jun. 30, 2020
|NOTE 15 - STOCKHOLDERS' EQUITY||
NOTE 15 - STOCKHOLDERS’ EQUITY
During the three months ended June 30, 2020 and 2019 outstanding nonqualified stock options were exercised in the amount of $0 and $99, respectively.
On October 6, 2017,the Company awarded restricted stock grants totalling 3,900,000 shares of its common stock to 16 employees and awarded nonqualified stock options to purchase an aggregate of 360,000 shares of its common stock to two employees. Of the 3,900,000 shares awarded pursuant to the restricted stock grant awards, 1,200,000 shares are subject to two-year vesting conditions and 2,700,000 shares are subject to three-year vesting conditions. All of the nonqualified stock options are subject to three-year vesting conditions. The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $525 during the three months ended June 30, 2020. The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $773 during the three months ended June 30, 2019.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef